Approaches such as single-cell transcriptomics or multiplex immunostaining will be instrumental in clarifying whether CXCL8 expression is tumor-intrinsic or derived from infiltrating immune cells, thereby enhancing our understanding of its prognostic and therapeutic relevance in a cell-type–specific context. This evidence concerns the gene CXCL8 and neoplasm.